Skip to main content

Select Drug Profiles

Original Research
The PCSK9 Inhibitors: A Novel Therapeutic Target Enters Clinical Practice
Norman E. Lepor, MD, Dean J. Kereiakes, MD
Read More
Perspectives
Employers Engaged in Benefit Design Innovation: Long-Term Trends in a 2015 National Survey
Cheryl Larson, F. Randy Vogenberg, PhD, FASHP
Read More
Original Research
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis
Joseph Tkacz, MS, Michael P. Ingham, MSc, Brenna L. Brady, PhD, Roxanne Meyer, PharmD, Charles Ruetsch, PhD
Stakeholder Perspective
You Cannot Manage What You Cannot Measure
by Sharon Glave Frazee, PhD, MPH
Read More
FDA Approvals, In the News
FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant
Read More
FDA Approvals, In the News
FDA Approves Bridion to Reverse Effects of Neuromuscular Blocking Drugs Used During Surgery
Read More
FDA Approvals, In the News
FDA Approves First Emergency Treatment for Overdose of Certain Types of Chemotherapy
Read More
FDA Approvals, In the News
FDA Approves New Oral Therapy to Treat ALK-Positive Lung Cancer
Read More
Mental Health
Faculty Perspectives: Mental Health Services and Emergency Department Use by Patients with Agitation Associated with Schizophrenia or Bipolar Disorder
Read More
FDA Approvals, In the News
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
Faculty Perspectives: Management of Adolescents and Adults with Asthma
Read More
Page 122 of 244
Results 1211 - 1220 of 2434